COMPOSITE RESPONDERS SHOWED IMPROVEMENT IN BOTH PENILE CURVATURE DEFORMITY AND SYMPTOM BOTHER IN TWO LARGE DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED PHASE 3 STUDIES OF COLLAGENASE CLOSTRIDIUM HISTOLYTICUM IN THE TREATMENT OF PEYRONIE'S DISEASE

被引：0
|
作者：
Hellstrom, Wayne
Feldman, Robert
Smith, Ted
Hobson, Sue
Tursi, James
Bernstein, Guy
机构：
来源：
JOURNAL OF UROLOGY | 2013年 / 189卷 / 04期
关键词：
D O I：
10.1016/j.juro.2013.02.3072
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
1658
引用
收藏
页码：E682 / E683
页数：2
相关论文
共 50 条
  • [31] A First Prospective, Randomized, Double-Blind, Placebo-Controlled Clinical Trial Evaluating Extracorporeal Shock Wave Therapy for the Treatment of Peyronie's Disease
    Palmieri, Alessandro
    Imbimbo, Ciro
    Longo, Nicola
    Fusco, Ferdinando
    Verze, Paolo
    Mangiapia, Francesco
    Creta, Massimiliano
    Mirone, Vincenzo
    EUROPEAN UROLOGY, 2009, 56 (02) : 363 - 369
  • [32] Impact of Psoriatic Arthritis Manifestations on Perception of Pain Improvement: Pooled Analysis of Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Studies with Guselkumab
    Nash, Peter
    McInnes, Iain
    Ritchlin, Christopher T.
    Tam, Lai-Shan
    Soriano, Enrique
    Starr, Michael
    Rampakakis, Emmanouil
    Lavie, Frederic
    Shawi, May
    Baraliakos, Xenofon
    Mease, Philip J.
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 2785 - 2787
  • [33] A Phase 2 Randomized, Double-blind, Placebo-controlled Trial of Ambroxol as a Disease-modifying Treatment for Parkinson's Disease Dementia
    Pasternak, S.
    Silveira, C.
    Coleman, K.
    Garcia, R.
    Wells, J.
    Borrie, M.
    MacDonald, P.
    Bartha, R.
    Jenkins, M.
    Morrow, S.
    Mendonca, D.
    Zou, G.
    Finger, E.
    Rupar, T.
    Tirona, R.
    Jog, M.
    MOVEMENT DISORDERS, 2023, 38 : S45 - S45
  • [34] Disability Severity Category Shift With Fremanezumab Treatment: Pooled Results of 3 Randomized, Double-Blind, Placebo-Controlled Phase 3 Studies
    Nagy, A. J.
    Cohen, J. M.
    Ning, X.
    Ramirez-Campos, V
    Janka, L.
    McAllister, P.
    HEADACHE, 2020, 60 : 11 - 11
  • [35] Difference in background factors between responders to gabapentin enacarbil treatment and responders to placebo: pooled analyses of two randomized, double-blind, placebo-controlled studies in Japanese patients with restless legs syndrome
    Inoue, Yuichi
    Hirata, Koichi
    Hoshino, Yuya
    Yamaguchi, Yusuke
    SLEEP MEDICINE, 2021, 85 : 138 - 146
  • [36] Liquid AbobotulinumtoxinA: Pooled Data From Two Double-Blind, Randomized, Placebo-Controlled Phase III Studies of Glabellar Line Treatment
    Hilton, Said
    Kestemont, Philippe
    Sattler, Gerhard
    Volteau, Magali
    Thompson, Catherine
    Andriopoulos, Bill
    Prygova, Inna
    Berg, Anna-Karin
    Ascher, Benjamin
    DERMATOLOGIC SURGERY, 2022, 48 (11) : 1198 - 1202
  • [37] Two phase 3, double-blind, placebo-controlled studies of the efficacy and safety of Astodrimer 1% Gel for the treatment of bacterial vaginosis
    Chavoustie, Steven E.
    Carter, Belvia A.
    Waldbaum, Arthur S.
    Donders, Gilbert G. G.
    Peters, Klaus H.
    Schwebke, Jane R.
    Paull, Jeremy R. A.
    Price, Clare F.
    Castellarnau, Alex
    McCloud, Philip
    Kinghorn, George R.
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2020, 245 : 13 - 18
  • [38] Randomized, Double-Blind, Placebo-Controlled Studies to Evaluate Treatment with Aducanumab (BIIB037) in Patients with Early Alzheimer's Disease: Phase 3 Study Design
    Viglietta, Vissia
    O'Gorman, John
    Williams, Lesile
    Tian, Ying
    Sandrock, Alfred
    Doody, Rachelle
    Salloway, Stephan
    Barkhof, Frederik
    Vellas, Bruno
    Sano, Mary
    Aisen, Paul
    Sevingy, Jeffery
    NEUROLOGY, 2016, 86
  • [39] Clinical trial: vitamin D3 treatment in Crohn's disease - a randomized double-blind placebo-controlled study
    Jorgensen, S. P.
    Agnholt, J.
    Glerup, H.
    Lyhne, S.
    Villadsen, G. E.
    Hvas, C. L.
    Bartels, L. E.
    Kelsen, J.
    Christensen, L. A.
    Dahlerup, J. F.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2010, 32 (03) : 377 - 383
  • [40] Cadazolid for the treatment of Clostridium difficile infection: results of two double-blind, placebo-controlled, non-inferiority, randomised phase 3 trials
    Gerding, Dale N.
    Cornely, Oliver A.
    Grill, Simon
    Kracker, Hilke
    Marrast, Anne Claire
    Nord, Carl Erik
    Talbot, George H.
    Buitrago, Martha
    Diaconescu, Iulian Gheorghe
    de Oliveira, Claudia Murta
    Preotescu, Liliana
    Pullman, John
    Louie, Thomas J.
    Wilcox, Mark H.
    LANCET INFECTIOUS DISEASES, 2019, 19 (03): : 265 - 274
12345